SEC Form 4 · accession 0001209191-18-056061
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Lerner
Director
Period of report
Oct 22, 2018
Accepted (ET)
Oct 24, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 22, 2018 | M | 12,500 | $1.50 | A | 66,911 | I | Held by the Lerner Family Trust UAD 11/14/94 |
| Common Stock | holding | — | — | — | 10,223 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $1.50 | Oct 22, 2018 | M | 12,500 | D | — | Dec 18, 2018 | Common Stock | 12,500 | 0 | I |
Explanation of responses
- F1Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.
- F2All shares underlying this option have vested.